Webdisclosure.com

Search

ADC THERAPEUTICS SA EQS-News: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors

Directive transparence : information réglementée

16/01/2019 07:00